Dedicated to Discovery. Committed to Care.

Center for AIDS Research (CFAR)

Funding Information

On this page

CFAR New Investigator Award

The Dana-Farber Cancer Institute-Beth Israel Deaconess Medical Center-Children's Hospital Center for AIDS Research is now accepting applications for the New Investigator Award. The purpose of this award is to provide initial research support, including salary and operating funds, for a newly-independent investigator to develop AIDS-related research activities.

Eligibility

The applicant must hold a faculty appointment at one of the participating institutions.

Funding Level

The New Investigator Award provides 50 percent of salary and fringe benefits, as well as $25,000 for supplies, small items of equipment and other materials.

The funding period is two years.

Application Deadlines

The next award will be offered in August 2002

Application Guidelines

  1. Research plan and summary
  2. Biographical sketch
  3. Other support

Application should be sent to:

CFAR Administrator
Department of Cancer Immunology and AIDS
832 Jimmy Fund Building
Dana-Farber Cancer Institute
44 Binney Street
Boston, MA 02115
(617) 632-4067

Top

Developmental Award

The purpose of this award is to stimulate and support the development of experimental and innovative approaches in the HIV/AIDS-related basic science research.

Who May Apply

Applicants must have a post-graduate degree and hold an appointment at the level of a Research Fellow, Instructor, or Assistant Professor at one of the three DFCI-BIDMC-CH CFAR participating institutions. There is no citizenship restriction. Both US citizens and non-US citizens are able to apply.

Funding Level and Project Duration

Up to eight proposals per year will be funded at a direct cost level of $20,000, which may include salary but not equipment or travel. The project period is one year starting September 1, 2002. There is a possibility to renew the award for a second year.

Application Deadlines

Applications are accepted on an annual basis and are awarded according to the following schedule:

  • Application Deadline: August 1, 2002
  • Application Review Completed: August 31, 2002
  • Funding Awarded: September 1, 2002

Review Process

Applications are evaluated by AIDS Research Review Committee (ARRC) based on the following criteria:

  1. Scientific merit of the proposal

    The AIDS Research Review Committee (ARRC) will consider the proposal's rational, as well as the expertise and resources available for this project within the investigator's laboratory.

  2. Relevance of the proposal to AIDS:

    Research studies must be relevant to HIV, HIV-related viruses, or AIDS and consequences of HIV infection (including opportunistic infections).

  3. Innovative aspects of the program:

    Research studies should be innovative and novel.

  4. New investigators:

    Applicants who are initiating AIDS-related research are especially encouraged to apply.

  5. Focus of application:

    The proposals should be specific and narrowly focused.

  6. Realistic goals:

    The goals and the schedule to meet them should be realistic.

  7. Prior approval where required:

    If necessary, the proposal must be reviewed and approved by the host institution's Biohazard Control Committee and the Animal Care and Use Committee (ACUC) prior to its consideration.

  8. Degree and appointment status:

    Applicants must have a post-graduate degree and hold an appointment at one of the participating institutions.

Application Guidelines

The proposed project cannot overlap with research that is already funded by the National Institute of Health.

NOTE: Applicants must submit evidence of the following with the application:

  • Certification of human subjects training
  • IRB approval
  • IACUC approval

Applicants should use the standard NIH RO1 format:

  1. Face page
  2. Abstract page
  3. Detailed budget for 12-month period and budget justification
  4. Biographical sketch
  5. Other support. Please list the applicant's other support as well the other support of his or her PI.
  6. Research Plan which should be a maximum of three pages and should include specific aims, background information, preliminary studies, research design, and methods
  7. Bibliography

Renewal Applications

Applications for a second year of funding will be considered. These applications should follow the above guidelines and, in addition, should include a brief report of progress made during the first year of the award. Any publications resulting from the first year of funding (or manuscripts submitted or in preparation) should be listed.

Conditions of Award

Awardees will be required to:

  • Submit progress reports to the CFAR director at the end of the project period.
  • Acknowledge CFAR support in all publications derived from CFAR funding.

Completed applications should be sent to:

Kerry McDonald
CFAR Administrator
Dana-Farber Cancer Institute
44 Binney St
JF 824
Boston, MA 02115
(617) 632-4067

Top

CFAR Clinical Research Pilot Project

The purpose of this award is to stimulate and support translational HIV/AIDS-related research.

Eligibility

Applicants must have a post-graduate degree and hold an appointment at the level of a Research Fellow, Instructor, or Assistant Professor at one of the three DFCI-BIDMC-CH CFAR participating institutions.

There is no citizenship restriction. Both US citizens and non-US citizens are able to apply.

Funding Level and Project Duration

Three proposals per year will be funded at a direct cost level of $20,000, which may include salary and supplies but not equipment or travel.

The project period is for one year starting September 1, 2002. There is a possibility to renew the award for a second year.

Application Deadlines

Applications are accepted on an annual basis and are awarded according to the following schedule:

  • Application Deadline: August 1, 2002
  • Application Review Completed: August 31, 2002
  • Funding Awarded: September 1, 2002

Review Process

Applications are evaluated by the CFAR Clinical Executive Committee (CCEC) based on the following criteria:

  1. Scientific merit of the proposal:

    The CFAR Clinical Executive Committee (CCEC) will consider the proposal's rationale.

  2. Likelihood that the research will lead to future funding:

    The applicant needs to demonstrate that this project will lead to future support.

  3. Relevance and importance to the field of HIV and AIDS:

    Research studies that are translational in nature must be relevant to HIV, HIV-related viruses, or AIDS and consequences of HIV infection (including opportunistic infections and neoplasms).

  4. New investigators:

    Scientists who are initiating AIDS-related clinical research are especially encouraged to apply.

  5. Collaborations:

    Collaborations with other CFAR members are strongly encouraged.

  6. Feasibility and realistic goals:

    The goals and the schedule to meet them should be realistic.

Application Guidelines

The proposed project cannot overlap with research that is already funded by the National Institute of Health.

  1. Clinical Section (maximum of three pages)

    • Title
    • Target Population/Patient Characteristics (age, sex, CD4 count, viral load, etc.)
    • Background/Rationale/Hypothesis
    • Objectives
    • Research Design and Methods
    • Laboratory Correlates
    • Endpoints/Statistical Considerations
    • Proposed Sample Size
    • Earliest date study can begin
  2. Let us know specifically how you envision that this project will lead to future funding opportunities. (1 paragraph)
  3. Detailed budget for the 12-month period and budget justification.
  4. Biographical sketch using the NIH format.
  5. Other support. Please list the applicant's other support as well the other support of his or her PI.
  6. Letter from mentor if the applicant is a fellow.

Renewal Applications

Applications for a second year of funding will be considered. These applications should follow the above guidelines and, in addition, should include a brief report of progress made during the first year of the award. Any publications resulting from the first year of funding (or manuscripts submitted or in preparation) should be listed.

Conditions of the Award

Awardees will be required to:

  • Submit progress reports to the Clinical Core Director at the end of the project period.
  • Acknowledge CFAR support in all publications derived from the CFAR funding.

Completed applications should be sent to:

Kerry McDonald
CFAR Administrator
Dana-Farber Cancer Institute
44 Binney St
JF 824
Boston, MA 02115
(617) 632-4067

Top

Federal Funding Information

The Medical Foundation Funding Opportunities

Postdoctoral Research Fellowships

Two-year stipends awarded to postdoctoral fellows with minimum of two, and a maximum of six, years of full-time postdoctoral experience at the time of application (November). Research areas include basic science, clinical research, and community health/epidemiology. Supported by the Charles A. King Trust (FleetBoston Financial, Co-Trustee) and additional private trusts and foundations, awards range from $32,000 - $38,000 depending on years of experience. Annual cycle with awards activating on July 1. Geographic area limited to Massachusetts.

Deborah Munroe Noonan Memorial Fund (Fleet, Trustee)

One-year grants, beginning in September, at $40,000 - $50,000 each, are awarded for demonstration projects aimed at improving the quality of life for children and adolescents with physical disabilities. Fund's geographic area limited to Metropolitan Boston.

Charles H. Farnsworth Trust (State Street Bank and Trust Company, Trustee)

One-year research grants, beginning in September, at $40,000 - $50,000 each. Projects must address both health-related and social issues that permit the elderly to function independently within their communities. Trust's geographic area limited to Massachusetts.

New Investigator Awards

Two-year grants of $50,000 per year awarded to newly appointed junior faculty conducting research in the areas of AIDS, cancer, cardiovascular disease, diabetes, neuroscience, and autism and related disorders. Principal funding provided by the Harcourt General Charitable Foundation with contributing support from the Jessie B. Cox Charitable Trust, the Dolphin Trust and the Nancy Lurie Marks Family Foundation (for research pertaining to autism). Annual cycle with awards activating on July 1. Geographic area limited to Massachusetts.

Child Health Research Grants:

Two-year grants of $50,000 per year, supported by the Charles H. Hood Foundation, awarded to junior faculty in academic and medical institutions within the six New England states (Maine, Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut). Grants support clinical or basic science research that will help to diminish health problems affecting the pediatric population. For grant application guidelines and forms, click here.

Top